Literature DB >> 25408936

Isolated central nervous system relapse of acute lymphoblastic leukemia.

Sang-Hyun Sung1, In-Seok Jang1.   

Abstract

Acute lymphoblastic leukemia (ALL) is the most common form of childhood cancer and may exhibit central nervous system (CNS) involvement. Advances in chemotherapy and effective CNS prophylaxis have significantly decreased the incidence of CNS relapse of ALL to 5-10%. Here, we report the case of a patient with isolated CNS relapse of standard risk group pre-B-cell type ALL in an 11-year-old girl, relapsed 3 years after successful completion of chemotherapy. An 11-year-old girl visited our hospital complaining of headache, dizziness, vomiting, and visual field defects. Neurological examination revealed left-side homonymous hemianopsia. Brain magnetic resonance imaging showed a large irregular dural-based sulcal hematoma in the right parietal and occipital lobes. Surgery to remove the hematoma revealed the existence of hematopoietic malignancy after pathologic evaluation. Bone marrow biopsy was subsequently performed but showed no evidence of malignancy.

Entities:  

Keywords:  Central nervous system; Leukemia; Recurrence

Year:  2014        PMID: 25408936      PMCID: PMC4231617          DOI: 10.14791/btrt.2014.2.2.114

Source DB:  PubMed          Journal:  Brain Tumor Res Treat        ISSN: 2288-2405


  12 in total

1.  Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study.

Authors:  Julio C Barredo; Meenakshi Devidas; Stephen J Lauer; Amy Billett; Maryanne Marymont; Jeanette Pullen; Bruce Camitta; Naomi Winick; William Carroll; A Kim Ritchey
Journal:  J Clin Oncol       Date:  2006-07-01       Impact factor: 44.544

2.  Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study .

Authors:  A K Ritchey; B H Pollock; S J Lauer; Y Andejeski; J Barredo; G R Buchanan
Journal:  J Clin Oncol       Date:  1999-12       Impact factor: 44.544

3.  Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.

Authors:  C D Mitchell; S M Richards; S E Kinsey; J Lilleyman; A Vora; T O B Eden
Journal:  Br J Haematol       Date:  2005-06       Impact factor: 6.998

Review 4.  Controversies in the management of central nervous system leukemia.

Authors:  Julio Barredo; A Kim Ritchey
Journal:  Pediatr Hematol Oncol       Date:  2010-08       Impact factor: 1.969

Review 5.  Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment.

Authors:  Ching-Hon Pui
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

6.  Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study.

Authors:  K Nguyen; M Devidas; S-C Cheng; M La; E A Raetz; W L Carroll; N J Winick; S P Hunger; P S Gaynon; M L Loh
Journal:  Leukemia       Date:  2008-09-25       Impact factor: 11.528

7.  Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Authors:  Nita L Seibel; Peter G Steinherz; Harland N Sather; James B Nachman; Cynthia Delaat; Lawrence J Ettinger; David R Freyer; Leonard A Mattano; Caroline A Hastings; Charles M Rubin; Kathy Bertolone; Janet L Franklin; Nyla A Heerema; Torrey L Mitchell; Allan F Pyesmany; Mei K La; Cheryl Edens; Paul S Gaynon
Journal:  Blood       Date:  2007-11-26       Impact factor: 22.113

8.  MR imaging of the brain in patients cured of acute lymphoblastic leukemia--the value of gradient echo imaging.

Authors:  M S M Chan; D J Roebuck; M-P Yuen; C-K Li; Y-L Chan
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

9.  Outcome after first relapse in children with acute lymphoblastic leukemia: a population-based study of 315 patients from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).

Authors:  H Schroeder; S Garwicz; J Kristinsson; M A Siimes; F Wesenberg; G Gustafsson
Journal:  Med Pediatr Oncol       Date:  1995-11

10.  Treating childhood acute lymphoblastic leukemia without cranial irradiation.

Authors:  Ching-Hon Pui; Dario Campana; Deqing Pei; W Paul Bowman; John T Sandlund; Sue C Kaste; Raul C Ribeiro; Jeffrey E Rubnitz; Susana C Raimondi; Mihaela Onciu; Elaine Coustan-Smith; Larry E Kun; Sima Jeha; Cheng Cheng; Scott C Howard; Vickey Simmons; Amy Bayles; Monika L Metzger; James M Boyett; Wing Leung; Rupert Handgretinger; James R Downing; William E Evans; Mary V Relling
Journal:  N Engl J Med       Date:  2009-06-25       Impact factor: 91.245

View more
  2 in total

1.  Lesions of the central nervous system in leukemia: Pathological and magnetic resonance imaging features at presentation in 14 patients.

Authors:  Jing Liu; Yaming Wang; Xuefei Sun; Shuo Liu; Zhenkun Yu; Nan Ji; Shengjun Sun; Yuanbo Liu
Journal:  Oncol Lett       Date:  2017-10-16       Impact factor: 2.967

2.  Transverse myelopathy occurring with intrathecal administration of methotrexate and cytarabine chemotherapy: A case report.

Authors:  Ying Pan; Chunhuai Wang; Huiping Wang; Qianshan Tao; Shudao Xiong; Zhimin Zhai
Journal:  Oncol Lett       Date:  2016-05-04       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.